Kemeriz, FundaTuğrul, BurcuYaşar, Erdoğan2022-02-072022-02-072022https://dx.doi.org/10.1016/j.abd.2021.05.008https://hdl.handle.net/20.500.12451/9172Background Previous studies has shown that dry eye test abnormalities, meibomian gland dysfunction (MGD), may occur in psoriasis. Objectives The authors aimed to evaluate the dry eye disease (DED), MGD, in psoriasis patients with meibography which is a current, objective, noninvasive method for patients with meibomian gland diseases, to investigate the relationship between disease severity and ocular involvement. Methods This study included 50 participants with psoriasis and 50 healthy individuals. All subjects were examined by the same dermatologist and referred for ophthalmological examination including meibomian gland obstruction, lid margin alterations assessment, ocular surface disease index assessment, tear film break-up time test, Schirmer test, corneal conjunctival fluorescein staining assessment. Additionally, upper and lower lids were evaluated for meibomian gland loss with meibography.eninfo:eu-repo/semantics/openAccessEye DiseasesMeibomian Gland DysfunctionPsoriasisArticle971222710.1016/j.abd.2021.05.00834785066Q2WOS:000748717000003Q3